In that cohort, 22% of WS patients with PAX3 variants presented with asymmetric or unilateral hearing loss, and the prevalence of hearing loss reached 43%, findings similar to those of Wang et al. (Poon et al., 2025). The gene discussed is PAX3; the disease is hearing loss disorder.